Showing 1 - 10 of 43,848
public expenditure, limiting financial exposure of patients, improving access to pharmaceuticals, and stimulating competition …
Persistent link: https://www.econbiz.de/10010224844
Persistent link: https://www.econbiz.de/10003756813
Persistent link: https://www.econbiz.de/10012506948
Persistent link: https://www.econbiz.de/10012816525
Persistent link: https://www.econbiz.de/10011986910
Persistent link: https://www.econbiz.de/10013431125
Persistent link: https://www.econbiz.de/10012197768
Persistent link: https://www.econbiz.de/10011708133
In this paper, I study the effect of parallel trade (cross border resale of goods without the authorization of the manufacturer) on pharmaceutical regulation in a North-South framework with a firm's endogenous decision to export to the South. Governments in both countries may limit prices...
Persistent link: https://www.econbiz.de/10011986314
Persistent link: https://www.econbiz.de/10012388590